Y35 Pill - purple capsule-shape, 14mm
Pill with imprint Y35 is Purple, Capsule-shape and has been identified as Lamotrigine Extended-Release 250 mg. It is supplied by Yiling Pharmaceutical, Inc.
Lamotrigine is used in the treatment of bipolar disorder; seizure prevention; epilepsy and belongs to the drug class triazine anticonvulsants. Risk cannot be ruled out during pregnancy. Lamotrigine 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Y35
Lamotrigine Extended-Release
- Imprint
- Y35
- Strength
- 250 mg
- Color
- Purple
- Size
- 14.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Triazine anticonvulsants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Yiling Pharmaceutical, Inc.
- National Drug Code (NDC)
- 69117-0048
Related images for "Y35"
More about lamotrigine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1,678)
- Drug images
- Latest FDA alerts (6)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: triazine anticonvulsants
- Breastfeeding
- En español
Patient resources
- Drug Information
- Lamotrigine Extended-Release Tablets
- Lamotrigine Tablets
- Lamotrigine Chewable Dispersible Tablets
- Lamotrigine Orally Disintegrating Tablets
Other brands
Lamictal, Lamictal XR, Lamictal ODT, Subvenite, Lamictal CD
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.